Design, synthesis, structure-activity relationship, and in vivo activity of azabicyclic aryl amides as alpha7 nicotinic acetylcholine receptor agonists.

A novel set of azabicyclic aryl amides have been identified as potent and selective agonists of the alpha7 nAChR. A two-pronged approach was taken to improve the potential hERG liability of previously disclosed alpha7 nAChR agonist, PNU-282,987, while maintaining the compound's other desirable pharmacological properties. The first approach involved further exploration of the aryl carboxylic acid fragment of PNU-282,987, while the second approach focused on modification of the azabicyclic amine portion of PNU-282,987. The best compounds from each series are characterized by rapid brain penetration, good oral bioavailability in rat, and demonstrate in vivo efficacy in a rat P50 auditory sensory gating assay. At least one analog from each series (1h, 1o, 2a, 9a, and 18a) shows an improved hERG safety profile over PNU-282,987.

[1]  M. Hajós.  Targeting information-processing deficit in schizophrenia: a novel approach to psychotherapeutic drug discovery. , 2006, Trends in pharmacological sciences.

[2]  P. J. Bouchard,et al.  Disubstituted Indazoles as Potent Antagonists of the Integrin αvβ3 , 2000 .

[3]  D. Donnelly-roberts,et al.  Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors. , 1998, Science.

[4]  D. Bertrand,et al.  Neuronal nicotinic acetylcholine receptors: from the gene to the disease , 2000, Behavioural Brain Research.

[5]  Thomas J. Raub,et al.  In vitro models of the blood-brain barrier. , 1998, Alternatives to laboratory animals : ATLA.

[6]  W. C. Still,et al.  Rapid chromatographic technique for preparative separations with moderate resolution , 1978 .

[7]  R. Papke,et al.  3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat α7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner , 1997, Brain Research.

[8]  J. Meltzer,et al.  Nicotinic cholinergic normalization of amphetamine-induced loss of auditory gating in freely moving rats , 1995, Psychopharmacology.

[9]  R. Myers,et al.  Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel. , 1991, Science.

[10]  G. Szakács,et al.  Functional Multidrug Resistance Protein (MRP1) Lacking the N-terminal Transmembrane Domain* , 1998, The Journal of Biological Chemistry.

[11]  G. Spalluto,et al.  A new approach to kainoids through tandem Michael reaction methodology: application to the enantioselective synthesis of (+)- and (-)-.alpha.-allokainic acid and to the formal synthesis of (-)-.alpha.-kainic acid , 1992 .

[12]  R. Papke,et al.  Characterization of a series of anabaseine-derived compounds reveals that the 3-(4)-dimethylaminocinnamylidine derivative is a selective agonist at neuronal nicotinic alpha 7/125I-alpha-bungarotoxin receptor subtypes. , 1995, Molecular pharmacology.

[13]  J. A. Dani,et al.  Overview of nicotinic receptors and their roles in the central nervous system , 2001, Biological Psychiatry.

[14]  Larry Miller,et al.  Separation of a racemic pharmaceutical intermediate using closed-loop steady state recycling , 1998 .

[15]  J. Daly.  Nicotinic Agonists, Antagonists, and Modulators From Natural Sources , 2005, Cellular and Molecular Neurobiology.

[16]  C. Swain,et al.  Novel 5-HT3 antagonists: indol-3-ylspiro(azabicycloalkane-3,5'(4'H)-oxazoles). , 1992, Journal of medicinal chemistry.

[17]  J S Ward,et al.  Functionally selective M1 muscarinic agonists. 3. Side chains and azacycles contributing to functional muscarinic selectivity among pyrazinylazacycles. , 1995, Journal of medicinal chemistry.

[18]  J. Macor,et al.  (-)-Spiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidin-2'-one], a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the alpha 7 nicotinic acetylcholine receptor. , 2000, Journal of medicinal chemistry.

[19]  A. Mazurov,et al.  Selective α7 Nicotinic Acetylcholine Receptor Ligands , 2006 .

[20]  M. Langlois,et al.  N-chloromethyl quinuclidinium derivatives: A new class of irreversible ligands for 5-HT3 receptors. , 1994 .

[21]  K. Seio,et al.  (+)-3-[2-(Benzo[b]thiophen-2-yl)-2-oxoethyl]-1-azabicyclo[2.2.2]octane as potent agonists for the alpha7 nicotinic acetylcholine receptor. , 2004, Bioorganic & medicinal chemistry letters.

[22]  D. Mckenna,et al.  Human α 7 nicotinic acetylcholine receptor responses to novel ligands , 1995, Neuropharmacology.

[23]  S. Viskin.  Long QT syndromes and torsade de pointes , 1999, The Lancet.

[24]  P. Potier,et al.  A practical synthesis of 1H-pyrrolo[2,3-c]pyridine-5-carboxylic acid derivatives from pyrrole-2-carboxaldehydes , 1993 .

[25]  J. Changeux,et al.  Chimaeric nicotinic–serotonergic receptor combines distinct ligand binding and channel specificities , 1993, Nature.

[26]  L. Munoz,et al.  Synthesis and evaluation of phenylcarbamate derivatives as ligands for nicotinic acetylcholine receptors. , 2004, Bioorganic & medicinal chemistry.

[27]  S. Ng,et al.  Synthesis and biological evaluation of 2-indolyloxazolines as a new class of tubulin polymerization inhibitors. Discovery of A-289099 as an orally active antitumor agent. , 2002, Bioorganic & medicinal chemistry letters.

[28]  L. Pannell,et al.  Epibatidine: a novel (chloropyridyl)azabicycloheptane with potent analgesic activity from an ecuadoran poison frog , 1992 .

[29]  E. Levin,et al.  Nicotinic acetylcholine involvement in cognitive function in animals , 1998, Psychopharmacology.

[30]  J K Lynch,et al.  Neuronal nicotinic acetylcholine receptors as targets for drug discovery. , 1997, Journal of medicinal chemistry.

[31]  John Saunders,et al.  Ester bio-isosteres: synthesis of oxadiazolyl-1-azabicyclo[2.2.1]heptanes as muscarinic agonists , 1988 .

[32]  J. Vaquero,et al.  Pyrrolodiazines. 5. Synthesis, Structure, and Chemistry of Pyrrolo[1,2-c]pyrimidine. Dipolar Cycloaddition of Pyrrolo[1,2-c]pyrimidinium Ylides , 1999 .

[33]  J. Schmitt,et al.  Exploring the nature of molecular recognition in nicotinic acetylcholine receptors. , 2000, Current medicinal chemistry.

[34]  J. Patrick,et al.  Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[35]  M. Romanelli,et al.  Cholinergic nicotinic receptors: Competitive ligands, allosteric modulators, and their potential applications , 2003, Medicinal research reviews.

[36]  A. Meyers,et al.  Total Synthesis of Bistratamide D. , 1999, The Journal of organic chemistry.

[37]  Michael Krause,et al.  Auditory sensory gating in hippocampus and reticular thalamic neurons in anesthetized rats , 2003, Biological Psychiatry.

[38]  C. Gotti,et al.  Neuronal nicotinic receptors, important new players in brain function. , 2000, European journal of pharmacology.

[39]  L. A. Carpino.  1-Hydroxy-7-azabenzotriazole. An efficient peptide coupling additive , 1993 .

[40]  Brian T. O’Neill,et al.  Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation , 2005 .

[41]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[42]  S. Arneric,et al.  Neuronal nicotinic receptors : pharmacology and therapeutic opportunities , 1999 .

[43]  Thomas J. Raub,et al.  Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity relationship. , 2006, Journal of medicinal chemistry.

[44]  G. Spalluto,et al.  Tandem michael reactions for the construction of pyrrolidine and piperidine ring systems , 1990 .

[45]  Gregory J Brewer,et al.  Isolation and culture of adult rat hippocampal neurons , 1997, Journal of Neuroscience Methods.

[46]  M. Trudell,et al.  A Short and Efficient Total Synthesis of (+/-)-Epibatidine. , 1996, The Journal of organic chemistry.

[47]  Jun Chen,et al.  A structural basis for drug-induced long QT syndrome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[48]  J. Boot,et al.  Recent progress in the development of subtype selective nicotinic acetylcholine receptor ligands. , 2002, Current drug targets. CNS and neurological disorders.

[49]  C. L. Shaffer,et al.  Using a Tritiated Compound to Elucidate Its Preclinical Metabolic and Excretory Pathways in Vivo: Exploring Tritium Exchange Risk , 2006, Drug Metabolism and Disposition.

[50]  E. Wong,et al.  Discovery and structure-activity relationship of quinuclidine benzamides as agonists of alpha7 nicotinic acetylcholine receptors. , 2005, Journal of medicinal chemistry.

[51]  P. Aristoff,et al.  Synthesis of benzopyran prostaglandins, potent stable prostacyclin analogs, via an intramolecular mitsunobu reaction , 1985 .

[52]  M. Dart,et al.  Design of ligands for the nicotinic acetylcholine receptors: the quest for selectivity. , 2004, Current topics in medicinal chemistry.

[53]  C. Swain,et al.  Novel 5-HT3 antagonists. Indole oxadiazoles. , 1991, Journal of medicinal chemistry.

[54]  R. Hurst,et al.  The Selective α7 Nicotinic Acetylcholine Receptor Agonist PNU-282987 [N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide Hydrochloride] Enhances GABAergic Synaptic Activity in Brain Slices and Restores Auditory Gating Deficits in Anesthetized Rats , 2005, Journal of Pharmacology and Experimental Therapeutics.

[55]  T. Hirata,et al.  Aminothiazolylglycyl derivatives of carbacephem antibiotics. II. Synthesis and antibacterial activity of novel aminothiazolyl cephem compounds with hydroxypyridone moiety. , 1987, The Journal of antibiotics.

[56]  S. Singh,et al.  Efficient synthesis of (±)-N-BOC-exo-2-(methoxycarbonyl)-7-Azabicyclo[2.2.1]heptane, a versatile intermediate for the synthesis of epibatidine and epiboxidine , 1997 .

[57]  G. Dondio,et al.  Selective kappa-opioid agonists: synthesis and structure-activity relationships of piperidines incorporating on oxo-containing acyl group. , 1994, Journal of medicinal chemistry.

[58]  T. Liljefors,et al.  Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations. , 2005, Journal of medicinal chemistry.

[59]  C M Grill,et al.  Closed-loop recycling with periodic intra-profile injection: a new binary preparative chromatographic technique. , 1998, Journal of chromatography. A.

[60]  M. Picciotto,et al.  Nicotinic Receptors in the Brain: Links between Molecular Biology and Behavior , 2000, Neuropsychopharmacology.

[61]  P. Thadeio,et al.  Tandem Michael addition and azanorbornane substance-P antagonists , 1997 .